Fingerprint
Dive into the research topics of 'Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma
Kartik Kesavabhotla, Cody D. Schlaff, Benjamin Shin, Lynn Mubita, Rachel Kaplan, Apostolos J. Tsiouris, Susan C. Pannullo, Paul Christos, Ehud Lavi, Ronald Scheff, John A. Boockvar
Research output: Contribution to journal › Article › peer-review
25
Scopus
citations